DRRA

Page not found | BioPharma Dive

Page not found | BioPharma Dive

[ad_1] Industry Dive is an Informa TechTarget business. This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world’s technology buyers and sellers. All copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget,…

Read More
5 Strategies to Manage CIDP Symptoms

5 Strategies to Manage CIDP Symptoms

[ad_1] Living with chronic inflammatory demyelinating polyneuropathy (CIDP) means managing symptoms that can range from frustrating to debilitating. Depending on the severity of your CIDP, you may experience tingling in your hands and feet, numbness, coordination problems, and impaired mobility that requires a wheelchair or walker. [1] [2] In addition to working with your neurologist…

Read More
What to Eat During Weeks 2–4 on GLP-1: Simple Protein-First Plan | glp-1, losing weight, medical weight loss and more

What to Eat During Weeks 2–4 on GLP-1: Simple Protein-First Plan | glp-1, losing weight, medical weight loss and more

[ad_1] Last updated: January 2026 Short answer: During weeks 2–4 on a GLP-1 journey, many people do best with a steady protein-first rhythm, gentle fiber, and hydration between meals. Appetite often feels more predictable than week one, which makes it easier to repeat simple meals that support energy and comfort without feeling overly full. Week…

Read More
3 Easy, Nourishing Salads – JSHealth

3 Easy, Nourishing Salads – JSHealth

[ad_1] At this time of year, I love coming back to food that feels fresh, grounding, and genuinely enjoyable. These three salads are simple to make, full of flavor, and perfect when you want nourishment without overthinking it. They’re satisfying, easy to pull together, and packed with wholesome ingredients, quality protein, and appetizing dressings. Let…

Read More
Pharmaceutical Executive Daily: Johnson & Johnson Continues  Billion Manufacturing Investment

Pharmaceutical Executive Daily: Johnson & Johnson Continues $55 Billion Manufacturing Investment

[ad_1] Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today’s Pharmaceutical Executive Daily, Johnson & Johnson reaches an agreement with the Trump administration while continuing its $55 billion U.S. investment plan, Bristol Myers Squibb outlines its long-term strategic focus at JPMorgan 2026, and…

Read More